Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
COLTENE: half-year sales and operating profit down – recovery expected in second half
COLTENE reports H1 2026 sales of CHF 112.8m (-4.4%; +0.8% in local currencies) and an operating profit of CHF 5.8m (-24%); the EBIT margin fell to 5.1%. Net profit decreased 5.0% to CHF 4.1m. Negative currency effects, higher material, logistics and energy costs, inventory optimizations in the US and local events in South America weighed on results; regionally, EMEA showed strong gains while Asia and South America declined. COLTENE confirms its outlook, expecting slight sales growth in local currencies for 2026, reiterates medium-term targets (organic growth 3–5% and EBIT margin 13–15% by 2028) and strengthens management with new leadership appointments. » More on finanzen.net
COLTENE delays medium-term targets to 2028 after profit slump
COLTENE saw falling sales and a sharp decline in profits last year. As a result, the previously set medium-term targets are now expected to be reached only in 2028. » More on finanzen.net
Coltene reports currency-adjusted revenue decline in 2025 and lower EBIT margin
Coltene reported preliminary 2025 figures: currency-adjusted revenue fell 4% to CHF 240.2 million and the stock dropped about 3.6%. The company expects an EBIT margin of 8.8% for 2025, well below its previous target of around 10%. Coltene reiterated its mid-term targets for 2027 of 3–5% organic growth and an EBIT margin of 13–15%. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 122.21m | - |
| Gross profit | 28.49m | - |
| Net profit | 4.39m | - |
| EBITDA | 9.86m | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €315.57m |
Number of shares | 5.98m |
52-week high/low | €64.25 - €46.39 |
Dividend yield | 4.06% |
Dividends TTM | €2.17 |
Beta | 0.81 |
P/E ratio | 19.64 |
PEG ratio | 5.87 |
P/B ratio | 3.11 |
P/S ratio | 1.23 |
Company profile
COLTENE Holding AG develops, manufactures, and sells disposables, tools, and equipment for dentists and dental laboratories in Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania. It offers restoration products, including conventional composites, bulk-fill composites, CAD/CAM solutions, core build-ups, bondings, etching gels, temporary materials, luting, curing lights, and characterizations; and endodontics products, such as posts, rotary and hand files, irrigation solutions, obturation and sealing materials, Gutta-percha and paper points, endo engines, apex locators, and endo accessories. The company also provides prosthetics comprising bite registration, retractions, A-silicones, C-silicones, and accessories; and treatment auxiliaries consisting of dental rolls and dispensers, cotton pellets and dispensers, aspirator tips, dental dams and dam kits, dental dam clamps and accessories, dental scalers, electrosurgery, and occlusion verification products. In addition, it offers infection control products, which include ultrasonic cleaning units, patient bibs, headrest covers, and sterile covers; rotary instruments, such as diamond and carbide burs, polishers, kits, and accessories; and laboratory products comprising gingiva masks, lab putty products, model making products, waxes, occlusion control products, accessories, HP burs, and silicone polishers. The company was formerly known as Medisize Holding AG and changed its name to COLTENE Holding AG in April 2008. COLTENE Holding AG was incorporated in 2005 and is headquartered in Altstätten, Switzerland.
| Name | Coltene Holding AG |
| CEO | Dominik Arnold |
| Headquarters | Altstätten,
sg Switzerland |
| Website | |
| IPO | 25/11/2009 |
| Employees | 1,137 |
Ticker symbols
| Exchange | Symbol |
|---|---|
SIX | CLTN.SW |
London Stock Exchange | 0QP7.L |
Pnk | CLHLF |
London | 0QP7.L |